Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516242 | SCV000613962 | uncertain significance | not specified | 2016-12-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000686319 | SCV000813833 | benign | LAMA2-related muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001796091 | SCV002032701 | uncertain significance | not provided | 2021-12-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV001796091 | SCV003808206 | uncertain significance | not provided | 2020-01-31 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001796091 | SCV005407989 | uncertain significance | not provided | 2024-08-12 | criteria provided, single submitter | clinical testing | BP4 |